Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease

doi:10.3748/wjg.v24.i36.4104

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 36

This Article

(364)

(358)

(0)

(29)

(13320)

(105)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Review

World J Gastroenterol. Sep 28, 2018; 24(36): 4104-4118
Published online Sep 28, 2018. doi: 10.3748/wjg.v24.i36.4104

Table 2 Summary of microRNAs associated with non-alcoholic fatty liver disease

miRNA	Source of samples	Change	Main targets
miR-9[129]	Human serum;	Upregulated	Onecut2; SIRT1
miR-9[129]	Human hepatocyte cell line	Upregulated	Onecut2; SIRT1
miR-10b[130]	Human hepatocyte cell line	Downregulated	PPARα
miR-15b[131,132]	Animal models	Upregulated
miR-15b[131,132]	Human serum	Upregulated
miR-16[104]	Human serum	Upregulated
miR-17[74]	Human liver	Downregulated
miR-19[84]	Human serum	Upregulated
miR-21[86,87,99,133-136]	Animal models	Upregulated	PPARα; TGF-β
	Human hepatocyte cell line		PTEN
	Human liver and serum		PTEN
miR-21[85,89,137,138]	Animal models	Downregulated	HMGCR; FABP7
	Human liver
	Human hepatocyte cell line
miR-24[139]	Animal models	Upregulated	Insig1; SREBP
miR-24[139]	Human hepatocyte cell line	Upregulated	Insig1; SREBP
miR-26[140]	Animal models	Downregulated	IL-6, IL-7
miR-27a[141]	Animal models	Downregulated
miR-27b[102]	Human serum	Upregulated
miR-29a[142,143]	Animal models	Downregulated	HMGCR; LPL
miR-29c[85,89,90]	Animal models	Downregulated	DNMT3A; DNMT3B
miR-30b[83]	Human liver	Downregulated	ITGAX; FABP4
miR-30b[83]	Human hepatocyte cell line	Downregulated	ITGAX; FABP4
miR-30c[144]	Human serum	Upregulated
miR-31[74,89]	Human liver	Upregulated
miR-31[74,89]	Animal models	Upregulated
miR-33a[73,76]	Human liver	Upregulated	ABCA1; ABCA2
miR-33a[85]	Human liver	Downregulated
MiR-34a[71,81,82,85,87,89,90,92,104,105,145-148]	Animal models	Upregulated	SIRT1; HNF4α; PPARα
	Human hepatocyte cell line
	Human liver and serum
miR-99a[149]	Human serum	Downregulated
miR-101[150]	Human hepatocyte cell line	Upregulated	ABCA1
miR-101[150]	Human monocyte cell line	Upregulated	ABCA1
miR-103[53,89,151]	Animal models	Upregulated	Cav1
miR-103[53,89,151]	Human liver and serum	Upregulated	Cav1
miR-103a[152]	Human liver	Upregulated
miR-103a[152]	Human hepatocyte cell line	Upregulated
miR-106b[152]	Human liver	Upregulated
miR-107[53,89]	Animal models	Upregulated	Cav1
miR-107[53,89]	Human liver	Upregulated	Cav1
miR-122[81,84,86,87,101-104,106,153]	Animal models	Upregulated
miR-122[81,84,86,87,101-104,106,153]	Human Serum	Upregulated
miR-122[71,82-85,89,90,99,106,141,154,155]	Animal models	Downregulated	ACC-2; HAMP; FAS; HMGCR; SREBF-1c
miR-122[71,82-85,89,90,99,106,141,154,155]	Human liver	Downregulated	SREPBF-2; HIF-1α; Vimentin; MAP3K3
miR-125b[84]	Human serum	Upregulated
miR-125b[156]	Animal models	Downregulated	FAS
miR-139-5p[83]	Human liver	Downregulated	TNFα
miR-144[76]	Human Liver	Upregulated	ABCA1
miR-144[157]	Animal models	Downregulated	TLR-2
miR-146a[158]	Animal models	Upregulated
miR-146a[158]	Human hepatocyte cell line	Upregulated
miR-146a[132]	Animal models	Downregulated	Wnt1; Wnt5
miR-146a[132]	Human hepatocyte cell line	Downregulated	Wnt1; Wnt5
Mir-146b[149,159]	Animal models	Downregulated	IRAK1
	Human serum		TRAF6
	Human hepatocyte cell line		TRAF6
miR-146b[71,83,158]	Animal models	Upregulated
	Human liver
	Human hepatocyte cell line
miR-149[160]	Animal models	Upregulated	FGF-21
miR-149[160]	Human hepatocyte cell line	Upregulated	FGF-21
miR-150[74]	Human liver	Upregulated
miR-152[158]	Animal models	Upregulated
miR-152[158]	Human hepatocyte cell line	Upregulated
miR-155[90,97-99,161,162]	Animal models	Upregulated	SOCS1; C/EBP-Β; CES3; PDGF; SMAD3
miR-155[90,97-99,161,162]	Human hepatocyte cell line	Upregulated	SOCS1; C/EBP-Β; CES3; PDGF; SMAD3
miR-155[96]	Animal models	Downregulated	LXRα
miR-155[96]	Human liver and serum	Downregulated	LXRα
miR-181a[82]	Animal models	Upregulated
miR-181d[149]	Human serum	Downregulated
miR-182[74]	Human liver	Upregulated	FOXO3
miR-183[74]	Human liver	Upregulated
miR-192[84,90]	Animal models	Downregulated
miR-192[84,90]	Human liver	Downregulated
miR-192-5p[82,84,86,102,106]	Animal models	Upregulated
miR-192-5p[82,84,86,102,106]	Human liver and serum	Upregulated
miR-194[89]	Animal models	Upregulated
miR-197[149]	Human serum	Downregulated
miR-199[163]	Animal models	Upregulated	Cav1; PPARα
	Human hepatocyte cell line
	Human liver
miR-200a/b/c[74,82,89,90,141,158,162,164]	Animal models	Upregulated	ZEB1; CDH1; EZH2; IRP1
miR-200a/b/c[74,82,89,90,141,158,162,164]	Human hepatocyte cell line	Upregulated	ZEB1; CDH1; EZH2; IRP1
miR-203[90,132]	Animal models	Downregulated
miR-212[165]	Animal models	Upregulated	FGF-21
miR-212[165]	Human hepatocyte cell line	Upregulated	FGF-21
miR-214[71,166]	Human liver	Upregulated
miR-214[71,166]	Animal models	Upregulated
miR-216[167]	Animal models	Downregulated
miR-219a[74]	Human liver	Downregulated
miR-221[73]	Human liver	Downregulated
miR-221[89,90,99]	Animal models	Upregulated
miR-222[99]	Animal models	Upregulated
miR-223[86,164]	Animals models	Upregulated	IRP1
miR-223[86,164]	Human serum	Upregulated	IRP1
miR-224[73,74]	Human liver	Upregulated
miR-291b[168]	Animal models	Upregulated	AMPKα1
miR-302a[167]	Animals model	Downregulated	ELOVL6
miR-331[144]	Human serum	Upregulated
miR-335[89]	Animal models	Upregulated
miR-375[84]	Human serum	Upregulated
miR-378i[74]	Human liver	Downregulated
miR-421[169]	Animal models	Upregulated	SIRT-3
miR-422a[83]	Human liver	Downregulated
miR-429[141]	Animal models	Upregulated
miR-451[87]	Human Serum	Upregulated
miR-451[89,141,170]	Animal models	Downregulated	AMPK/AKT
miR-451[89,141,170]	Human liver	Downregulated	AMPK/AKT
miR-467b[171]	Animal models	Downregulated	LPL
miR-576[152]	Human liver	Downregulated	RAC1
miR-576[152]	Human hepatocyte cell line	Downregulated	RAC1
miR-590[74]	Human liver	Downregulated
miR-892a[152]	Human liver	Upregulated
miR-892a[152]	Human hepatocyte cell line	Upregulated
miR-1290[102]	Human serum	Upregulated

Onecut2: One cut homeobox 2; SIRT: Sirtuin; PPARα: Peroxisome proliferator activated receptor α; TGF-β: Transforming growth factor β; PTEN: Phosphatase and tensin homolog; HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase; FABP: Fatty acid binding protein; Insig1: Insulin induced gene 1; SREBP: Sterol regulatory element binding protein; IL: Interleukin; LPL: Lipoprotein lipase; DNMT: DNA methyltransferase; ITGAX: Integrin subunit α X; ABCA: ATP binding cassette subfamily A; HNF4α: Hepatocyte nuclear factor 4 α; Cav1: Caveolin 1; ACC-2: Acetyl-CoA carboxylase 2; SREBF: Sterol regulatory element binding transcription factor; HIF-1α: Hypoxia inducible factor 1 α; MAP3K3: Mitogen-activated protein kinase kinase kinase 3; FAS: Fatty acid synthase; TNFα: Tumour necrosis factor α; TLR-2: Toll-like receptor 2; Wnt: Wnt family member; IRAK1: Interleukin 1 receptor associated kinase 1; TRAF6: TNF receptor associated factor 6; FGF-21: Fibroblast growth factor 21; SOCS1: Suppressor of cytokine signaling 1; C/EBPβ: CCAAT/enhancer binding protein β; CES3: Carboxylesterase 3; PDGF: Platelet derived growth factor; SMAD3: SMAD family member 3; LXRα: Liver X receptor; FOXO3: Forkhead box O3; ZEB-1: Zinc finger E-box binding homeobox 1; CDH1: Cadherin 1; EZH2: Enhancer of zeste 2 polycomb repressive complex 2; IRP1: Iron regulatory protein 1; AMPKα1: AMPK: Adenosine monophosphate activated protein kinase α 1; ELOVL6: ELOVL fatty acid elongase 6; AMPK: Adenosine monophosphate activated protein kinase; AKT: AKT serine/threonine kinase 1; RAC1: Ras-related C3 botulinum toxin substrate 1.

Full Size Table

Citation: Torres JL, Novo-Veleiro I, Manzanedo L, Alvela-Suárez L, Macías R, Laso FJ, Marcos M. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. World J Gastroenterol 2018; 24(36): 4104-4118
URL: https://www.wjgnet.com/1007-9327/full/v24/i36/4104.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i36.4104

Torres JL, Novo-Veleiro I, Manzanedo L, Alvela-Suárez L, Macías R, Laso FJ, Marcos M. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. World J Gastroenterol 2018; 24(36): 4104-4118 [PMID: 30271077 DOI: 10.3748/wjg.v24.i36.4104]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.